Riskpilot← Back to searchSign inGet full accessHELSEFARMA ApS
APSActiveCVR 18394545Sømandshvile Park 25Engineering activities and related technical consultancy · NACE 7112Est. 19941 employees
Revenue 2024
DKK -12K
-81% vs 2023
EBITDA margin
2190.6%
+17% vs 2023
Equity ratio
97.9%
Financial strength
Net profit 2024
DKK 1,1M
+595% vs 2023
| Revenue | DKK -12K | -81% |
| EBITDA | DKK -253K | +17% |
| Net profit | DKK 1,1M | +595% |
| Total assets | DKK 1,1M | +2528% |
| Equity | DKK 1,1M | +6798% |
| Employees | 1 | — |
Legal name
HELSEFARMA ApS
CVR number
18394545
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
31. december 1994
Share capital
DKK 200.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at investere i virksomheder, der driver fabrikation og handel og anden dermed beslægtet virksomhed
Address
Sømandshvile Park 25
Phone
+4539637724
Email
doritmoller@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -145 | 27 | -31 | -36 | -55 | -42 | -51 | -44 | -43 | -36 | -51 | -62 | -12 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -60 | -241 | -241 | -241 |
| EBITDA | -145 | 27 | -31 | -36 | -55 | -42 | -51 | -44 | -43 | -95 | -291 | -303 | -253 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -145 | 27 | -31 | -36 | -55 | -42 | -51 | -44 | -43 | -95 | -291 | -303 | -253 |
| Net financials | 297 | 508 | 661 | 800 | 59 | 485 | 389 | 479 | 1.290 | -820 | -54 | 86 | 1.324 |
| Profit before tax | 152 | 535 | 630 | 764 | 5 | 443 | 338 | 435 | 1.247 | -915 | -345 | -216 | 1.072 |
| Tax | 24 | -0 | -0 | -0 | -12 | 12 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 128 | 535 | 630 | 764 | 17 | 431 | 338 | 435 | 1.247 | -915 | -345 | -216 | 1.072 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.355 | 1.438 | 1.437 | 1.623 | 1.460 | 1.173 | 819 | 865 | 1.813 | 608 | 262 | 42 | 1.111 |
| Equity | 884 | 1.418 | 1.401 | 1.465 | 1.381 | 1.153 | 691 | 845 | 1.593 | 578 | 232 | 16 | 1.087 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 471 | 20 | 36 | 158 | 79 | 20 | 128 | 20 | 221 | 30 | 30 | 26 | 23 |
| Total debt | 471 | 20 | 36 | 158 | 79 | 20 | 128 | 20 | 221 | 30 | 30 | 26 | 23 |
EBITDA margin
-25290400.0%
This company
15.8%
Market median
-160065923% vs market
20122024
Equity ratio
97.9%
This company
38.2%
Market median
+156% vs market
20122024
Return on equity
98.6%
This company
18.4%
Market median
+436% vs market
20122024
Net profit margin
107157000.0%
This company
8.1%
Market median
+1322925826% vs market
20122024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20122024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HS Audit | Audit | 2003 | — | — |
SM Founder | Founder | 1994 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HELSEFARMA ApS 
PHARMAZAN PHARMACEUTICALS ApSBoard members of HELSEFARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henning Siemsen | Audit | 0 companies |
| Steffen Møller | Founder | 0 companies |